Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (
NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on Thursday August 14, 2025, before opening of the Nasdaq CM.
